BeyondSpring Inc. Disposal Group, Including Discontinued Operation, Liabilities, Current
BeyondSpring Inc. (BYSI) had Disposal Group, Including Discontinued Operation, Liabilities, Current of $10.79 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2026-08-14
- 2026-06-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $10.79M.
- 2026-03-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $9.26M.
- 2025-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $11.13M.
- 2025-09-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $10.61M.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Current |
|---|---|
| 2026-06-30 | $10.79M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $9.26M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $11.13M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $10.61M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $9.62M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $9.73M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $8.81M 10-K · filed 2026-03-25 |
| 2023-12-31 | $3.72M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |